Josephine Cucchiaro - Concepedia

Author

Josephine Cucchiaro

Vion Pharmaceuticals (United States)

Also Known As

J. Cucchiaro, Josephine B. Cucchiaro, Josephine Cucchiaro, Josephine Cucchiaro, PhD

133

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Vion Pharmaceuticals (United States)Sunovion (United States)New York Medical College University of Miami State University of New York

About

Josephine Cucchiaro is an author at Vion Pharmaceuticals (United States) specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	984
2	Social Sciences	8	8	676
3	Biology	1	1	116
4	Cell Biology	1	1	116
5	Cognitive Science	1	1	95

Josephine Cucchiaro

Publications

Citations

H-Index

Page 1

	Year	Citations
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study Antony Loebel, Josephine Cucchiaro, Robert Silva, American Journal of Psychiatry	2013	335
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study Trisha Suppes, Robert Silva, Josephine Cucchiaro, American Journal of Psychiatry	2015	313
The dorsal lateral geniculate nucleus of the normal ferret and its postnatal development D. Card Linden, R. W. Guillery, Josephine Cucchiaro The Journal of Comparative Neurology	1981	308
Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study Antony Loebel, Josephine Cucchiaro, Robert Silva, American Journal of Psychiatry Adjunctive TherapyAdverse EventsPsychiatryMood SymptomMedicine	2013	287
Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study Herbert Y. Meltzer, Josephine Cucchiaro, Robert Silva, American Journal of Psychiatry	2011	248
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial Richard S.E. Keefe, Kolleen H. Fox, Philip D. Harvey, Schizophrenia Research PsychiatryPsychotic DisorderMedicineSchizophreniaSocial Sciences	2010	228
Lurasidone in the Treatment of Acute Schizophrenia Mitsutaka Nakamura, Masaaki Ogasa, John Guarino, The Journal of Clinical Psychiatry	2009	192
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial Antony Loebel, Josephine Cucchiaro, Kaushik Sarma, Schizophrenia Research	2013	171
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study Henry A. Nasrallah, Robert Silva, Debra Phillips, Journal of Psychiatric Research PsychotherapyPsychiatryPsychotic DisorderPsychotropic MedicationPsychotic Patients	2013	147
Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study Melissa P. DelBello, Robert Goldman, Debra Phillips, Journal of the American Academy of Child & Adolescent Psychiatry	2017	125

Page 1